Fund details
Concentrates on innovations that push the boundaries of human performance, aiming for technological advances that amplify human capabilities.
Go to profile
Partners related to this fund
John Harris
Managing Partner
John has extensive experience as an entrepreneur and operating executive in life sciences and technology. He founded NeuroVista, a company developing new treatments for epilepsy, and Northstar Neuroscience, which went public in 2006. He also founded Heartstream, which revolutionized cardiac arrest treatment through portable defibrillators that are now commonplace worldwide.
Investor scope
Investment criteria breakdown.
Investment stages
Seed
Series A
Series B+
Target regions
USA
Investment ranges
$0 - $100K
$100K - $500K
$500K - $1M
$1M - $3M
$3M - $10M
Focus areas
Enterprise
Biotech
Health
AI
Gaming & VR
Related unicorns
A glimpse at some of the $1B+ valuation companies backed by this fund.
Related Sector Funds
Funds investing in similar sectors.
.svg)
